Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma
帕博利珠单抗辅助治疗与IFNα2b或伊匹木单抗治疗切除的高危黑色素瘤的比较
期刊:Cancer Discovery
影响因子:33.3
doi:10.1158/2159-8290.CD-21-1141
Grossmann, Kenneth F; Othus, Megan; Patel, Sapna P; Tarhini, Ahmad A; Sondak, Vernon K; Knopp, Michael V; Petrella, Teresa M; Truong, Thach-Giao; Khushalani, Nikhil I; Cohen, Justine V; Buchbinder, Elizabeth I; Kendra, Kari; Funchain, Pauline; Lewis, Karl D; Conry, Robert M; Chmielowski, Bartosz; Kudchadkar, Ragini R; Johnson, Douglas B; Li, Hongli; Moon, James; Eroglu, Zeynep; Gastman, Brian; Kovacsovics-Bankowski, Magdalena; Gunturu, Krishna S; Ebbinghaus, Scot W; Ahsan, Sama; Ibrahim, Nageatte; Sharon, Elad; Korde, Larissa A; Kirkwood, John M; Ribas, Antoni